Monday, March 05, 2018

2nd Annual Manufacturers’ 340B Summit

2nd Annual Manufacturers’ 340B Summit
May 15-16, 2018 | Philadelphia, PA

Join pharmaceutical manufacturers, legal experts, thought leaders, and leading regulatory strategists at World Congress’ 2nd Annual Manufacturers’ 340B Summit, May 16-17, in Philadelphia. This premier event is your first opportunity of 2018 to hear critical updates on finalized regulations and ensure you have the internal strategies in place to effectively execute 340B processes.

How will you benefit from attending?
  • Hear directly from your peers on how they are navigating the regulatory and operational challenges including: AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and many more
  • The best and brightest legal minds will be here to aid you with navigating nuances associated with Government Programs, including: Alice Vander-Curran, John Shakow, Bill Sarraille, Kristin Hicks, and Donna Lee Yesner just to name a few
  • This is your opportunity to meet with key states including Delaware and North Carolina, to discuss state plan amendments and healthcare reform around 340B
  • Network with Covered Entities to foster collaboration and brainstorm on best practices
Executives from J&J, EMD Serono, Merck, Sagent Pharmaceuticals, Grifols, Luitpold, Pfizer, Lilly, Incyte are already signed up for this event. Shouldn’t you be there?

Register with discount code DC200 and save an additional $200 on current early bird rates - starting at $1125 for pharmaceutical manufacturers.

Can’t leave the office? Live stream this event from the convenience of your office.

This event, co-located with the 3rd Annual Covered Entities’ 340B Summit, provides comprehensive coverage of the 340B program.

CPE Credits and CLE Credits* are available.

*CLE Pending approval

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment